These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8989717)

  • 81. Melatonin dispensing among New Zealand children aged 0-18 years with autism: a nationwide cross-sectional study.
    McLay LK; Schluter PJ; Eggleston MJF; Woodford EC; Bowden N
    Sleep Med; 2021 Apr; 80():184-192. PubMed ID: 33601231
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effectiveness of melatonin for sleep problems in autism spectrum disorders: evidence grows but research is still needed.
    Guénolé F; Baleyte JM
    J Autism Dev Disord; 2011 Jul; 41(7):974-5. PubMed ID: 20865448
    [No Abstract]   [Full Text] [Related]  

  • 83. Use of melatonin: a single-centre audit.
    Dack R; Garstang JJ
    BMJ Paediatr Open; 2022 Feb; 6(1):. PubMed ID: 36053610
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Melatonin and development: physiology and pharmacology.
    Kennaway DJ
    Semin Perinatol; 2000 Aug; 24(4):258-66. PubMed ID: 10975432
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Sleep problems in dementia].
    Oka Y
    Rinsho Shinkeigaku; 2014; 54(12):994-6. PubMed ID: 25672690
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Study protocol for a randomised controlled trial examining the association between physical activity and sleep quality in children with autism spectrum disorder based on the melatonin-mediated mechanism model.
    Tse ACY; Lee PH; Zhang J; Lai EWH
    BMJ Open; 2018 Apr; 8(4):e020944. PubMed ID: 29654045
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials.
    Zhang W; Chen XY; Su SW; Jia QZ; Ding T; Zhu ZN; Zhang T
    Neurol Sci; 2016 Jan; 37(1):57-65. PubMed ID: 26255301
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Immediate and prolonged-release melatonin in children with neurodevelopmental disabilities. Author reply to Prof. Zisapel.
    Bruni O; Alonso-Alconada D; Besag F; Biran V; Braam W; Cortese S; Moavero R; Parisi P; Smits M; Van der Heijden K; Curatolo P
    Eur J Paediatr Neurol; 2017 Mar; 21(2):420-421. PubMed ID: 28187823
    [No Abstract]   [Full Text] [Related]  

  • 89. Melatonin for insomnia in children with autism spectrum disorders.
    Andersen IM; Kaczmarska J; McGrew SG; Malow BA
    J Child Neurol; 2008 May; 23(5):482-5. PubMed ID: 18182647
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis.
    Braam W; Smits MG; Didden R; Korzilius H; Van Geijlswijk IM; Curfs LM
    Dev Med Child Neurol; 2009 May; 51(5):340-9. PubMed ID: 19379289
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The use of chronobiotics in the resynchronization of the sleep-wake cycle.
    Cardinali DP; Furio AM; Reyes MP; Brusco LI
    Cancer Causes Control; 2006 May; 17(4):601-9. PubMed ID: 16596316
    [TBL] [Abstract][Full Text] [Related]  

  • 92. What is melatonin? Is it a useful treatment for sleep problems in autism?
    Lord C
    J Autism Dev Disord; 1998 Aug; 28(4):345-6. PubMed ID: 9711493
    [No Abstract]   [Full Text] [Related]  

  • 93. The therapeutic potential of melatonin: a review of the science.
    Malhotra S; Sawhney G; Pandhi P
    MedGenMed; 2004 Apr; 6(2):46. PubMed ID: 15266271
    [No Abstract]   [Full Text] [Related]  

  • 94. Pharmacological and non-pharmacological management of sleep disturbance in children: an Australian Paediatric Research Network survey.
    Heussler H; Chan P; Price AM; Waters K; Davey MJ; Hiscock H
    Sleep Med; 2013 Feb; 14(2):189-94. PubMed ID: 23245853
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Circadian Rhythm Disturbances in the Blind.
    Hartley S; Dauvilliers Y; Quera-Salva MA
    Curr Neurol Neurosci Rep; 2018 Aug; 18(10):65. PubMed ID: 30083814
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: A systematic review and meta-analysis.
    Salanitro M; Wrigley T; Ghabra H; de Haan E; Hill CM; Solmi M; Cortese S
    Neurosci Biobehav Rev; 2022 Aug; 139():104723. PubMed ID: 35691474
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Sleep disorders in children with neurologic diseases.
    Zucconi M; Bruni O
    Semin Pediatr Neurol; 2001 Dec; 8(4):258-75. PubMed ID: 11768788
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Hypothermia Associated With Melatonin Ingestion in a Child With Autism.
    Erden S
    Clin Neuropharmacol; 2019; 42(5):179-180. PubMed ID: 31348013
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Sleep Problems and Melatonin Use in School-aged Children.
    He D; Niu W
    JAMA Pediatr; 2020 Mar; 174(3):300-301. PubMed ID: 31904832
    [No Abstract]   [Full Text] [Related]  

  • 100. Use of nutritional supplements based on melatonin, tryptophan and vitamin B6 (Melamil Tripto®) in children with primary chronic headache, with or without sleep disorders: a pilot study.
    Bravaccio C; Terrone G; Rizzo R; Gulisano M; Tosi M; Curatolo P; Emberti Gialloreti L
    Minerva Pediatr; 2020 Feb; 72(1):30-36. PubMed ID: 31621274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.